CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis

CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis

Abstract Background Treatment with anti-tuberculosis drugs may cause patients to experience serious adverse effects. Genetic factors, such as polymorphisms of CYP genes, may increase the likelihood of a patient experiencing such adverse drug reactions. In this systematic review and meta-analysis, we...

Full description

Bibliographic Details
Main Authors:	Marty Richardson, Jamie Kirkham, Kerry Dwan, Derek J. Sloan, Geraint Davies, Andrea L. Jorgensen
Format:	Article
Language:	English
Published:	BMC 2018-11-01
Series:	Systematic Reviews
Subjects:	Tuberculosis Pharmacogenetics Toxicity Meta-analysis
Online Access:	http://link.springer.com/article/10.1186/s13643-018-0861-z

Similar Items

Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)
by: Marty Richardson, et al.
Published: (2017-07-01)

Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities
by: Evelien G. E. Hurkmans, et al.
Published: (2020-08-01)

The prevalence of allelic variants of VKORC1, CYP2C9 and CYP4F2 genes in Zaporizhzhia region population
by: M. Yu. Kolesnik, et al.
Published: (2019-03-01)

Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients
by: María A. Lavanderos, et al.
Published: (2019-03-01)

Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients
by: L. Cortejoso, et al.
Published: (2014-07-01)

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
by: Felicia Stefania Falvella, et al.
Published: (2015-04-01)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
by: Guillermo eGervasini, et al.
Published: (2012-11-01)

STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline.
by: Marty Chaplin, et al.
Published: (2020-09-01)

Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Lin Cheng, et al.
Published: (2021-04-01)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018-06-01)

<i>MTHFR</i> and <i>VDR</i> Polymorphisms Improve the Prognostic Value of <i>MYCN</i> Status on Overall Survival in Neuroblastoma Patients
by: Gladys G. Olivera, et al.
Published: (2020-04-01)

Nanomedicine: pharmacological perspectives
by: Bhattacharya Santanu, et al.
Published: (2012-06-01)

Common CYP2D6, CYP2C9, and CYP2C19 Gene Variants, Health Anxiety, and Neuroticism Are Not Associated With Self-Reported Antidepressant Side Effects
by: Simran Maggo, et al.
Published: (2019-11-01)

Frequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population
by: Filipp Filippovich Vasilyev, et al.
Published: (2016-01-01)

An Evaluation of the Diagnostic Accuracy of a Panel of Variants in <i>DPYD</i> and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities
by: Claire Palles, et al.
Published: (2021-03-01)

Rol de la farmacogenómica en el régimen de tratamiento de tuberculosis
by: Heinner Guio, et al.

Identification and functional characterization of genetic variants in the human indoleamine 2, 3-dioxygenase (INDO) gene
by: Arefayene, Million
Published: (2008)

Inter-ethnic genetic variations and novel variant identification in the partial sequences of CYP2B6 gene in Pakistani population
by: Sagheer Ahmed, et al.
Published: (2021-07-01)

The influence of CYP2C19*2 and CYP3A5*3 variants on the development of depression and effectiveness of therapy: A preliminary study
by: Rafał Świechowski, et al.
Published: (2021-10-01)

Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
by: Claudia Maria Hattinger, et al.
Published: (2020-06-01)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
by: Elena Arrigoni, et al.
Published: (2017-01-01)

The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol
by: James D. Millard, et al.
Published: (2019-12-01)

Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
by: Giada Scantamburlo, et al.
Published: (2017-10-01)

Influencia de polimorfismos genéticos de CYP3A4/5 en la farmacocinética de levonorgestrel: estudio piloto
by: Iván Moreno, et al.
Published: (2012-12-01)

Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: The first meta-analysis of Russian prospective studies
by: D A Sychev, et al.
Published: (2014-04-01)

Bilateral tubercular mastitis
by: Kant Surya, et al.
Published: (2007-01-01)

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying <i>CYP2D6</i>*4 Variants: A Case Report
by: Céline K. Stäuble, et al.
Published: (2021-06-01)

Tubercular monoarthritis of wrist
by: Prakash Joshi, et al.
Published: (2017-01-01)

Status Asetilator Gen NAT2 pada Pasien Tuberkulosis dan Tuberkulosis dengan Diabetes Melitus di Kupang, Nusa Tenggara Timur
by: Alvinsyah Adhityo Pramono, et al.
Published: (2017-03-01)

Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa
by: Srinivas Reddy Pallerla, et al.
Published: (2021-03-01)

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol
by: Ana Hernández-Guío, et al.
Published: (2021-05-01)

Male reproductive toxicity of zearalenone—meta-analysis with mechanism review
by: Lin Li, et al.
Published: (2021-09-01)

A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease
by: Maria Tziastoudi, et al.
Published: (2021-04-01)

The Human Cytochrome P450 (<it>CYP</it>) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects
by: Sim Sarah C, et al.
Published: (2010-04-01)

Pharmacogenetics of CYP2D6 and CYP2C19 as a pre-prescription tool for drug efficacy and toxicity in a demographically-representative sample of theSouth African population
by: Dodgen, Tyren Mark
Published: (2014)

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer
by: L. N. Lyubchenko, et al.
Published: (2017-10-01)

Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact
by: Melissa A Chiasson, et al.
Published: (2020-09-01)

Tubercular Lesions in Otolaryngology - Our Experience
by: Manaswini Mallick, et al.
Published: (2013-06-01)

Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients
by: Yoomi Park, et al.
Published: (2019-06-01)

Frequency of CYP2D6 Alleles Including Structural Variants in the United States
by: Andria L. Del Tredici, et al.
Published: (2018-04-01)